艾尔建

艾尔建
Allergan plc
艾尔建; Allergan plc
公司類型	上市公司
ISIN	IE00BY9D5467
成立	2013年5月16日，11年前
營業據點數	40家生产工厂，27家全球研发中心和全球销售营销部门
業務範圍	100个国家
产业	制药工程
營業額	▼ 157.87亿美元 (2018年)
净利润	▼ 51.42亿美元 (2018年)
總資產	▼ 1017.87亿美元 (2018年)
資產淨值	▼ 651.31亿美元 (2018年)
所有權者	艾伯维
員工人數	17,800 (2018)
网站	www.allergan.com
備註

艾尔建(英語：Allergan plc)是一家爱尔兰制药公司。^[2]^[1]

历史

1950年创建于美国欧文，1970年在纽约证券交易所挂牌上市，2009年进入中国市场，2015年被爱尔兰制药公司阿特维斯以700亿美元收购并将总部迁往都柏林以避税。^[3]^[4]合并后的公司依然使用艾尔建名字，目前公司有眼科, 神经康复及医疗美容相关产品。

2019年6月，美国制药公司AbbVie宣布已达成协议，以630亿美元收购艾尔建。

参考来源

^ ^1.0 ^1.1 Allergan plc 2018 Form 10-K Annual Report. U.S. Securities and Exchange Commission.
^ Jonathan D. Rockoff; Nina Trentmann. New Tax Law Haunts Inversion Deals. The Wall Street Journal. 11 February 2018. Similarly, Allergan, a drugmaker that moved its headquarters to Ireland after a 2013 acquisition but gets about 80% of revenue in the U.S., expects the loss of deductions on intercompany loans will largely be balanced out by lower taxes on its U.S. sales.
^ From Actavis to Allergan: One pharma company's wild dealmaking journey. Forbes Magazine. 30 July 2015. For a master class in mergers and acquisitions, one need only look at the company formerly known as Actavis. Now called Allergan, after its $70 billion acquisition of that maker of Botox last fall, the pharmaceutical firm has undertaken a dizzying series of deals in just the last few years, reinventing and renaming itself in a fashion that might make the artist formerly known as The Artist Formerly Known As Prince proud.
^ Liz Hoffman. The Tax Inversion Wave Keeps Rolling. Wall Street Journal. 7 July 2015. Horizon and other inverted companies are using their new, lower tax rates to turbocharge corporate takeovers. Applying those rates, often in the midteens, to profits of companies in the U.S., with a federal corporate rate of 35%, can yield extra savings on top of those traditionally wrung from mergers. Moreover, unlike the U.S., Ireland and most other countries, only tax profits earned in-country, giving companies the freedom and incentive to shift income to still-lower-tax jurisdictions.

外部链接

官方网站

- Allergan plc的商業數據：Google Finance
- Yahoo! Finance
- Reuters
- SEC filings
- Bloomberg

[10K-1] 1.0 ^1.1 Allergan plc 2018 Form 10-K Annual Report. U.S. Securities and Exchange Commission.

[wsj1-2] Jonathan D. Rockoff; Nina Trentmann. New Tax Law Haunts Inversion Deals. The Wall Street Journal. 11 February 2018. Similarly, Allergan, a drugmaker that moved its headquarters to Ireland after a 2013 acquisition but gets about 80% of revenue in the U.S., expects the loss of deductions on intercompany loans will largely be balanced out by lower taxes on its U.S. sales.

[activis_deals-3] From Actavis to Allergan: One pharma company's wild dealmaking journey. Forbes Magazine. 30 July 2015. For a master class in mergers and acquisitions, one need only look at the company formerly known as Actavis. Now called Allergan, after its $70 billion acquisition of that maker of Botox last fall, the pharmaceutical firm has undertaken a dizzying series of deals in just the last few years, reinventing and renaming itself in a fashion that might make the artist formerly known as The Artist Formerly Known As Prince proud.

[wsjinversions-4] Liz Hoffman. The Tax Inversion Wave Keeps Rolling. Wall Street Journal. 7 July 2015. Horizon and other inverted companies are using their new, lower tax rates to turbocharge corporate takeovers. Applying those rates, often in the midteens, to profits of companies in the U.S., with a federal corporate rate of 35%, can yield extra savings on top of those traditionally wrung from mergers. Moreover, unlike the U.S., Ireland and most other countries, only tax profits earned in-country, giving companies the freedom and incentive to shift income to still-lower-tax jurisdictions.

[1]

[2]

[3]

[4]